FIELMANN AG (ADR/1/5)O.N. (FIE1) - Total Liabilities
Based on the latest financial reports, FIELMANN AG (ADR/1/5)O.N. (FIE1) has total liabilities worth €1.42 Billion EUR (≈ $1.66 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore FIELMANN AG (ADR/1/5)O.N. annual equity growth to track the company's year-over-year net asset growth rate.
FIELMANN AG (ADR/1/5)O.N. - Total Liabilities Trend (2021–2024)
This chart illustrates how FIELMANN AG (ADR/1/5)O.N.'s total liabilities have evolved over time, based on quarterly financial data. See FIELMANN AG (ADR/1/5)O.N. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
FIELMANN AG (ADR/1/5)O.N. Competitors by Total Liabilities
The table below lists competitors of FIELMANN AG (ADR/1/5)O.N. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bohai Leasing Co Ltd
SHE:000415
|
China | CN¥240.27 Billion |
|
Tsingtao Brewery Company Limited
F:TSI
|
Germany | €21.60 Billion |
|
KINGDEE INT. UNS.ADR/100
F:KDID
|
Germany | €6.38 Billion |
|
Parabilis Medicines, Inc. Common Stock
NASDAQ:PBLS
|
USA | $139.95 Million |
|
Emcure Pharmaceuticals Ltd
NSE:EMCURE
|
India | Rs46.36 Billion |
|
Nuvama Wealth
NSE:NUVAMA
|
India | Rs204.64 Billion |
|
Dorman Products Inc
NASDAQ:DORM
|
USA | $968.43 Million |
|
Xinjiang Tianshan Cement Co Ltd
SHE:000877
|
China | CN¥192.09 Billion |
Liability Composition Analysis (2021–2024)
This chart breaks down FIELMANN AG (ADR/1/5)O.N.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see FIELMANN AG (ADR/1/5)O.N. stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.48 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.59 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how FIELMANN AG (ADR/1/5)O.N.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for FIELMANN AG (ADR/1/5)O.N. (2021–2024)
The table below shows the annual total liabilities of FIELMANN AG (ADR/1/5)O.N. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €1.46 Billion ≈ $1.70 Billion |
+24.58% |
| 2023-12-31 | €1.17 Billion ≈ $1.37 Billion |
+27.92% |
| 2022-12-31 | €913.48 Million ≈ $1.07 Billion |
+5.84% |
| 2021-12-31 | €863.09 Million ≈ $1.01 Billion |
-- |
About FIELMANN AG (ADR/1/5)O.N.
Fielmann Group AG engages in vision care and audiology business in Germany, Switzerland, Austria, Spain, North America, and internationally. The company manufactures and sells visual aids mainly glasses, eyewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems and its accessories, as well as personal protective equipment. It offers its products under the fielmann, Optik… Read more